Olympus Continuum Launches – A Comprehensive Global Educational Platform Specifically for Healthcare Professionals

February 1, 2021

Olympus Continuum is a new comprehensive educational platform designed to provide healthcare professionals all over the world with learning opportunities and training to put their skills into practice and keep them performing at their best.

The “Olympus Continuum” platform will empower HCPs at every stage of their career with innovative, premium education and specialized training experiences. The platform builds on the existing Olympus training program, which trains more than 25,000 HCPs annually over 1,400 courses.

Chief Medical Officer, Ross D. Segan, MD, MBA, FACS, said: “Healthcare professionals work in a variety of settings and have a multitude of needs–and their expectations for training courses have evolved well past traditional skills-based learning. Our new platform connects the continuum of care with the continuum of learning. A truly blended experience, Olympus Continuum maximizes digital self-guided pre-learning, direct in-person training, and post-learning collaboration to support healthcare professional across every stage of their career and to improve patient outcome.”

HCPs using the “Olympus Continuum” platform will enjoy the following benefits:

– Comprehensive platform programs covering basic to advanced levels: The Olympus global professional education strategy is to establish a continuum of blended learning that takes HCPs from basic to advanced, providing more educational opportunities/experiences and increasing accessibility through the utilization of technology. Hands-on courses will be provided in our 15 dedicated Olympus training labs, as well as hospitals and other labs all over the world.

– Beneficial for remote areas, including emerging countries: In some emerging countries and hard-to-reach areas, it has been difficult for HCPs to receive training or enroll in educational programs because of limited course offerings and large geographical distances. “Olympus Continuum” is a globalized and comprehensive platform of training and education experiences led by healthcare experts from around the world.

– Effective platform that fits well with current conditions created by the COVID-19 pandemic: There was growing demand from healthcare professionals for on-demand, digitally-enabled virtual training and this has increased further during the current COVID-19 pandemic. This new platform exactly meets this demand and provides an excellent combination of virtual and on-site training.

Learning opportunities include hands-on courses, online learning, lectures and workshops, peer-to-peer training, accredited continuing education and on-demand learning

SourceOlympus

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”